Skip to the page

Data / Drug companies / Xuzhou Lanting Pharmaceutical Co., Ltd

Xuzhou Lanting Pharmaceutical Co., Ltd: 8 products in the FDA NDC directory, labeler code 85323

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Xuzhou Lanting Pharmaceutical Co., Ltd (labeler code 85323) lists 8 products in the FDA National Drug Code Directory, covering 4 finished drugs by generic name. By type: 8 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on June 10, 2025.

The request: Watch Xuzhou Lanting Pharmaceutical Co., Ltd (FDA labeler code 85323): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
85323
Products in commercial distribution
8
Packages
8
Finished drugs by generic name
4
Prescription products
0
Over the counter products
8
Flagged as original packager
8 of 8 products that carry the flag
Started marketing in the last 12 months
0
Earliest marketing start
March 1, 2025
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Over the counter monograph drugs8100%

Products by type

TypeProductsShare
Over the counter drugs8100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Pain relief patch34
Pain relief patch, pain relief strip21
Capsaicin pain relief patch, capsaicin pain relief strip21
Lidocaine pain relief patch15

Dosage forms

Dosage formProductsShare
Patch8100%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
3% Menthol plus 0.083% Capsaicin Pain Relief Patch85323-008PatchOver the counter monograph drugsJune 10, 2025
5% Menthol Pain Relief Patch85323-007PatchOver the counter monograph drugsJune 10, 2025
5% Menthol Pain Relief Patch85323-006PatchOver the counter monograph drugsJune 10, 2025
0.025% Capsaicin Pain relief Patch85323-005PatchOver the counter monograph drugsJune 10, 2025
5% Menthol Pain Relief Patch85323-004PatchOver the counter monograph drugsMarch 1, 2025
4% lidocaine plus 1% menthol Pain Relief Patch85323-003PatchOver the counter monograph drugsMarch 1, 2025
4% Lidocaine Pain Relief Patch85323-002PatchOver the counter monograph drugsMarch 1, 2025
0.025% Capsaicin Pain relief Patch85323-001PatchOver the counter monograph drugsMarch 1, 2025

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.